Current Synthetic and Systems Biology
Open Access

Oligonucleotides in Gene Editing and Genetic Engineering

Olivier Elemento^{* *}Correspondence: Olivier Elemento, Department of Genetic Engineering, University of Nebraska-Lincoln, Lincoln, Nebraska, USA, Email:

Author info »

Description

Oligonucleotides are short strands of nucleotides that can be synthesized in the laboratory for various applications in molecular biology, biotechnology, and medicine. They are typically composed of 10-50 nucleotides and can be designed to target specific DNA or RNA sequences. There are several types of oligonucleotides, including primers, probes, antisense oligonucleotides, and aptamers.

Each type has a unique structure and function, but all are used to interact with nucleic acids in some way. Primers are short oligonucleotides that are used in polymerase chain reaction (PCR) to initiate DNA amplification. They bind to a specific region of the DNA sequence and provide a starting point for the DNA polymerase enzyme to copy the target sequence.

Probes are another type of oligonucleotide that is used in various applications, such as in situ hybridization and gene expression analysis. Probes are labeled with fluorescent or radioactive tags and can bind to complementary DNA or RNA sequences in a sample. By detecting the location or abundance of specific nucleic acid sequences, probes can provide valuable information about gene expression, genetic mutations, or the presence of infectious agents. Antisense oligonucleotides are designed to bind to specific messenger RNA (mRNA) molecules and inhibit their translation into protein. This approach has potential applications in the treatment of genetic diseases and cancer, where the aberrant expression of certain genes can lead to disease.

Aptamers are short, single-stranded oligonucleotides that are designed to bind to specific target molecules, such as proteins, small molecules, or cells. Aptamers can be used in a variety of applications, such as in diagnostic assays, drug delivery, and therapeutics. The oligonucleotide synthesis involves the stepwise addition of nucleotides to a growing chain. The process can be automated and scaled up for large-scale production of oligonucleotides. There are several methods of synthesis, including solid-phase synthesis, solution-phase synthesis, and enzymatic synthesis. Solid-phase synthesis is the most common method used for synthesizing oligonucleotides.

It involves attaching the first nucleotide to a solid support, then sequentially adding each subsequent nucleotide, one at a time, until the desired sequence is achieved. The oligonucleotide is then cleaved from the solid support and purified. Solution-phase synthesis involves synthesizing the oligonucleotide in solution, rather than on a solid support. This method is less commonly used but can be useful for synthesizing certain types of oligonucleotides.

Enzymatic synthesis uses enzymes, such as DNA polymerase or RNA polymerase, to add nucleotides to a growing chain. This method is less commonly used but can be useful for synthesizing complex oligonucleotides. Oligonucleotides have numerous applications in molecular biology, biotechnology, and medicine. They can be used in diagnostics, therapeutics, and gene editing. For example, antisense oligonucleotides have shown promise in treating genetic diseases, such as spinal muscular atrophy, while aptamers have potential applications in targeted drug delivery.

In this, oligonucleotides are short strands of nucleotides that can be synthesized in the laboratory for various applications in molecular biology, biotechnology, and medicine. They have numerous applications, including in diagnostics, therapeutics, and gene editing. There are several types of oligonucleotides, each with a unique structure and function. The synthesis of oligonucleotides can be automated and scaled up for large-scale production. Oligonucleotides continue to be an important tool in the fields of molecular biology, biotechnology, and medicine, and their potential for new applications.